SM
ITCI

Sabby Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Sabby Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35,000
Closed -$1.11M – 215
2020
Q4 		$1.11M Sell
35,000
-80,000
-70% -$2.1M 1.07% 47
2020
Q3 		$2.95M Buy
+115,000
New +$2.62M 2.67% 33
2016
Q4 		– Sell
-14,800
Closed -$209K – 377
2016
Q3 		$226K Sell
14,800
-57,143
-79% -$2.31M 0.08% 270
2016
Q2 		$2.79M Sell
71,943
-6,057
-8% -$218K 0.97% 87
2016
Q1 		$2.17M Buy
+78,000
New +$2.6M 0.44% 92
2015
Q2 		– Sell
-100,000
Closed -$2.54M – 413
2015
Q1 		$2.39M Buy
+100,000
New +$2.24M 0.67% 131

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return